EUVIMEDEUVIMED entdecken
Leserbrief

Hormone/HER2 receptor crosstalk in breast cancer needs further investigation

Kadri Altundag

Medical Oncology · 2024

DOI: 10.1007/s12032-024-02383-9 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Medical Oncology, 2024. Verfasst von Kadri Altundag. Beteiligte Einrichtung: MKA Breast Cancer Clinic, Tepe Prime, 06800, Cankaya, Ankara, Turkey. altundag66@yahoo.com. Hauptthemen laut MEDLINE: Breast Neoplasms, Erb-b2 Receptor Tyrosine Kinases. Die Arbeit nennt 3 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsErb-b2 Receptor Tyrosine KinasesHumansFemaleReceptors, EstrogenReceptors, ProgesteroneReceptor Cross-Talk

Substanzen

Erb-b2 Receptor Tyrosine KinasesReceptors, EstrogenReceptors, Progesterone

Autor:innen und Institutionen

  • MKA Breast Cancer Clinic, Tepe Prime, 06800, Cankaya, Ankara, Turkey. altundag66@yahoo.com.

Zitieren

APA

Altundag, K. (2024). Hormone/HER2 receptor crosstalk in breast cancer needs further investigation. Medical Oncology. https://doi.org/10.1007/s12032-024-02383-9

Vancouver

Altundag K. Hormone/HER2 receptor crosstalk in breast cancer needs further investigation. Medical Oncology. 2024. doi:10.1007/s12032-024-02383-9

BibTeX
@article{Altundag2024,
  author = {Altundag, Kadri},
  title = {Hormone/HER2 receptor crosstalk in breast cancer needs further investigation},
  journal = {Medical Oncology},
  year = {2024},
  doi = {10.1007/s12032-024-02383-9}
}
Kostenlos starten →